Applied Policy ®

Menu

Archive Tag: Drug Price Transparency

Health, Persistent Theme in President Trump’s State of the Union Address

In last night’s State of the Union, President Trump addressed a number of health care related issues including prescription drug pricing, health care costs, and the defeat of HIV in the United States. On Prescription Drugs “Already, as a result of my Administration's efforts, in 2018 drug prices experienced their single largest decline in 46 years.  [...] Read More

Will the Drug Pricing Transparency Rule Work?

On Monday, the Trump Administration released a high-profile proposed rule that, if implemented, would require drug manufacturers to disclose the list prices of prescription drugs in their respective direct-to-consumer (DTC) advertisements (see AP’s summary of the proposal here). Trying to stay ahead of the curve, PhRMA also released voluntary guidelines for member companies in which [...] Read More